{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:31:58Z","timestamp":1790746318377,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s40266-023-01059-9","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T09:29:09Z","timestamp":1692782949000},"page":"933-940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy and Safety of Dupilumab in Older Patients (Aged 80 Years and Above) with Atopic Dermatitis: A Prospective Study"],"prefix":"10.1007","volume":"40","author":[{"given":"Xiyuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9648-3219","authenticated-orcid":false,"given":"Lixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"issue":"2","key":"1059_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jaad.2018.09.035","volume":"80","author":"YW Yew","year":"2019","unstructured":"Yew YW, Thyssen JP, Silverberg JI. A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. J Am Acad Dermatol. 2019;80(2):390\u2013401.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1059_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.clindermatol.2017.03.007","volume":"35","author":"NB Silverberg","year":"2017","unstructured":"Silverberg NB. Typical and atypical clinical appearance of atopic dermatitis. Clin Dermatol. 2017;35(4):354\u20139.","journal-title":"Clin Dermatol"},{"issue":"Suppl. 1","key":"1059_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/ggi.12771","volume":"16","author":"R Tanei","year":"2016","unstructured":"Tanei R, Hasegawa Y. Atopic dermatitis in older adults: a viewpoint from geriatric dermatology. Geriatr Gerontol Int. 2016;16(Suppl. 1):75\u201386.","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"1059_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/bjd.18652","volume":"182","author":"S Williamson","year":"2020","unstructured":"Williamson S, Merritt J, De Benedetto A. Atopic dermatitis in the elderly: a review of clinical and pathophysiological hallmarks. Br J Dermatol. 2020;182(1):47\u201354.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1059_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40266-020-00750-5","volume":"37","author":"R Tanei","year":"2020","unstructured":"Tanei R. Atopic dermatitis in older adults: a review of treatment options. Drugs Aging. 2020;37(3):149\u201360.","journal-title":"Drugs Aging"},{"issue":"10","key":"1059_CR6","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1111\/jdv.16346","volume":"34","author":"S Wang","year":"2020","unstructured":"Wang S, Zhu R, Gu C, et al. Distinct clinical features and serum cytokine pattern of elderly atopic dermatitis in China. J Eur Acad Dermatol Venereol. 2020;34(10):2346\u201352.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10258","key":"1059_CR7","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","author":"GBDD Collaborators","year":"2020","unstructured":"Collaborators GBDD. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1160\u2013203.","journal-title":"Lancet"},{"key":"1059_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101174","volume":"64","author":"EF Fang","year":"2020","unstructured":"Fang EF, Xie C, Schenkel JA, et al. A research agenda for ageing in China in the 21st century (2nd edition): focusing on basic and translational research, long-term care, policy and social networks. Ageing Res Rev. 2020;64: 101174.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"1059_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00391-022-02079-7","volume":"55","author":"P Dovjak","year":"2022","unstructured":"Dovjak P. Frailty in older adults with heart disease. Z Gerontol Geriatr. 2022;55(6):465\u201370.","journal-title":"Z Gerontol Geriatr"},{"issue":"8\u20139","key":"1059_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.neurol.2010.03.008","volume":"166","author":"B Croisile","year":"2010","unstructured":"Croisile B, Astier JL, Beaumont C, et al. The five-word test in three age-groups of mild Alzheimer\u2019s disease (60, 70 and 80 year-old patients): utility of the total score, total weighted score, learning score and memory score. Rev Neurol (Paris). 2010;166(8\u20139):711\u201320.","journal-title":"Rev Neurol (Paris)."},{"key":"1059_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108078","volume":"162","author":"A Sinclair","year":"2020","unstructured":"Sinclair A, Saeedi P, Kaundal A, et al. Diabetes and global ageing among 65\u201399-year-old adults: findings from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2020;162: 108078.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"1059_CR12","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1097\/CCM.0000000000002407","volume":"45","author":"M Commereuc","year":"2017","unstructured":"Commereuc M, Guerot E, Charles-Nelson A, et al. ICU patients requiring renal replacement therapy initiation: fewer survivors and more dialysis dependents from 80 years old. Crit Care Med. 2017;45(8):e772\u201381.","journal-title":"Crit Care Med"},{"issue":"62","key":"1059_CR13","doi-asserted-by":"publisher","first-page":"eabl4340","DOI":"10.1126\/sciimmunol.abl4340","volume":"6","author":"P Bastard","year":"2021","unstructured":"Bastard P, Gervais A, Le Voyer T. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021;6(62):eabl4340.","journal-title":"Sci Immunol"},{"issue":"2","key":"1059_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jdv.16928","volume":"35","author":"AS Paller","year":"2021","unstructured":"Paller AS, Siegfried EC, Simpson EL. A phase 2, open-label study of single-dose dupilumab in children aged 6 months to < 6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy. J Eur Acad Dermatol Venereol. 2021;35(2):464\u201375.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1059_CR15","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.jaad.2020.02.060","volume":"82","author":"JI Silverberg","year":"2020","unstructured":"Silverberg JI, Yosipovitch G, Simpson EL, et al. Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS. J Am Acad Dermatol. 2020;82(6):1328\u201336.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1059_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s40257-021-00597-5","volume":"22","author":"C Patruno","year":"2021","unstructured":"Patruno C, Fabbrocini G, Longo G, et al. Effectiveness and safety of long-term dupilumab treatment in elderly patients with atopic dermatitis: a multicenter real-life observational study. Am J Clin Dermatol. 2021;22(4):581\u20136.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"1059_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40257-022-00754-4","volume":"24","author":"JI Silverberg","year":"2023","unstructured":"Silverberg JI, Lynde CW, Abuabara K, et al. Efficacy and safety of dupilumab maintained in adults \u226560 years of age with moderate-to-severe atopic dermatitis: analysis of pooled data from four randomized clinical trials. Am J Clin Dermatol. 2023;24(3):469\u201383.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"1059_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","volume":"70","author":"LF Eichenfield","year":"2014","unstructured":"Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338\u201351.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"1059_CR19","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/jdv.16910","volume":"34","author":"C Vestergaard","year":"2020","unstructured":"Vestergaard C. Expanding the phenotype and endophenotype of AD. J Eur Acad Dermatol Venereol. 2020;34(10):2017.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"1059_CR20","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1172\/JCI117919","volume":"95","author":"R Ghadially","year":"1995","unstructured":"Ghadially R, Brown BE, Sequeira-Martin SM, et al. The aged epidermal permeability barrier: structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Investig. 1995;95(5):2281\u201390.","journal-title":"J Clin Investig"},{"issue":"1","key":"1059_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jaci.2019.01.015","volume":"144","author":"L Zhou","year":"2019","unstructured":"Zhou L, Leonard A, Pavel AB, et al. Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol. 2019;144(1):144\u201356.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1059_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/jcm4050979","volume":"4","author":"R Tanei","year":"2015","unstructured":"Tanei R. Clinical characteristics, treatments, and prognosis of atopic eczema in the elderly. J Clin Med. 2015;4(5):979\u201397.","journal-title":"J Clin Med"},{"issue":"2","key":"1059_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.18176\/jiaci.0682","volume":"32","author":"FJ Munoz-Bellido","year":"2022","unstructured":"Munoz-Bellido FJ, Moreno E, Davila I. Dupilumab: a review of present indications and off-label uses. J Investig Allergol Clin Immunol. 2022;32(2):97\u2013115.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"1059_CR24","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/jdv.17094","volume":"35","author":"C Patruno","year":"2021","unstructured":"Patruno C, Napolitano M, Argenziano G, et al. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study. J Eur Acad Dermatol Venereol. 2021;35(4):958\u201364.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1S","key":"1059_CR25","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1097\/DER.0000000000000686","volume":"32","author":"F Russov","year":"2021","unstructured":"Russov F, Milanesi N, Cartocci A, et al. Dupilumab in elderly patients with severe atopic dermatitis. Dermatitis. 2021;32(1S):S24\u20137.","journal-title":"Dermatitis"},{"issue":"3","key":"1059_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/genes1030413","volume":"1","author":"A Borchers","year":"2010","unstructured":"Borchers A, Pieler T. Programming pluripotent precursor cells derived from Xenopus embryos to generate specific tissues and organs. Genes (Basel). 2010;1(3):413\u201326.","journal-title":"Genes (Basel)"},{"issue":"11","key":"1059_CR27","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1111\/all.15439","volume":"77","author":"LS Spekhorst","year":"2022","unstructured":"Spekhorst LS, Bakker D, Drylewicz J, et al. Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis. Allergy. 2022;77(11):3398\u2013407.","journal-title":"Allergy"},{"issue":"6","key":"1059_CR28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/cpdd.798","volume":"9","author":"Z Li","year":"2020","unstructured":"Li Z, Radin A, Li M, et al. Pharmacokinetics, pharmacodynamics, safety, and tolerability of dupilumab in healthy adult subjects. Clin Pharmacol Drug Dev. 2020;9(6):742\u201355.","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"4","key":"1059_CR29","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jaad.2020.11.042","volume":"84","author":"Y Wang","year":"2021","unstructured":"Wang Y, Jorizzo JL. Retrospective analysis of adverse events with dupilumab reported to the United States Food and Drug Administration. J Am Acad Dermatol. 2021;84(4):1010\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1059_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/BOR.0b013e3283025ec2","volume":"20","author":"J Keane","year":"2008","unstructured":"Keane J, Bresnihan B. Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies. Curr Opin Rheumatol. 2008;20(4):443\u20139.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"1059_CR31","first-page":"5","volume":"23","author":"A Cinats","year":"2018","unstructured":"Cinats A, Heck E, Robertson L. Janus kinase inhibitors: a review of their emerging applications in dermatology. Skin Ther Lett. 2018;23(3):5\u20139.","journal-title":"Skin Ther Lett"},{"issue":"4","key":"1059_CR32","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/jdv.16866","volume":"35","author":"M Nogueira","year":"2021","unstructured":"Nogueira M, Warren RB, Torres T. Risk of tuberculosis reactivation with interleukin (IL)-17 and IL-23 inhibitors in psoriasis: time for a paradigm change. J Eur Acad Dermatol Venereol. 2021;35(4):824\u201334.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1059_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec","author":"CC Dobler","year":"2016","unstructured":"Dobler CC. Biologic agents and tuberculosis. Microbiol Spectr. 2016. https:\/\/doi.org\/10.1128\/microbiolspec.","journal-title":"Microbiol Spectr."},{"issue":"1","key":"1059_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaci.2015.10.023","volume":"137","author":"M Her","year":"2016","unstructured":"Her M, Kavanaugh A. Alterations in immune function with biologic therapies for autoimmune disease. J Allergy Clin Immunol. 2016;137(1):19\u201327.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1059_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri3831","volume":"15","author":"TA Wynn","year":"2015","unstructured":"Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015;15(5):271\u201382.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"1059_CR36","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nri2199","volume":"7","author":"RM Anthony","year":"2007","unstructured":"Anthony RM, Rutitzky LI, Urban JF Jr, et al. Protective immune mechanisms in helminth infection. Nat Rev Immunol. 2007;7(12):975\u201387.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1059_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40257-019-00445-7","volume":"20","author":"LF Eichenfield","year":"2019","unstructured":"Eichenfield LF, Bieber T, Beck LA, et al. Infections in dupilumab clinical trials in atopic dermatitis: a comprehensive pooled analysis. Am J Clin Dermatol. 2019;20(3):443\u201356.","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl. 2","key":"1059_CR38","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.1016\/j.ijtb.2022.10.001","volume":"69","author":"M Vishnu Sharma","year":"2022","unstructured":"Vishnu Sharma M, Arora VK, Anupama N. Challenges in diagnosis and treatment of tuberculosis in elderly. Indian J Tuberc. 2022;69(Suppl. 2):S205\u20138.","journal-title":"Indian J Tuberc"},{"issue":"1","key":"1059_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40249-019-0614-9","volume":"9","author":"J Cheng","year":"2020","unstructured":"Cheng J, Sun YN, Zhang CY, et al. Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study. Infect Dis Poverty. 2020;9(1):13.","journal-title":"Infect Dis Poverty"},{"issue":"3","key":"1059_CR40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s12016-022-08934-0","volume":"62","author":"A Kychygina","year":"2022","unstructured":"Kychygina A, Cassagne M, Tauber M, et al. Dupilumab-associated adverse events during treatment of allergic diseases. Clin Rev Allergy Immunol. 2022;62(3):519\u201333.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"1059_CR41","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/ajd.13846","volume":"63","author":"F Casale","year":"2022","unstructured":"Casale F, Nguyen C, Dobry A, et al. Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis. Australas J Dermatol. 2022;63(3):394\u20137.","journal-title":"Australas J Dermatol"},{"issue":"4","key":"1059_CR42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1159\/000530608","volume":"239","author":"Z Su","year":"2023","unstructured":"Su Z, Zeng YP. Dupilumab-associated psoriasis and psoriasiform manifestations: a scoping review. Dermatology. 2023;239(4):646\u201357.","journal-title":"Dermatology"},{"issue":"15","key":"1059_CR43","volume":"6","author":"AN Donlan","year":"2021","unstructured":"Donlan AN, Sutherland TE, Marie C, et al. IL-13 is a driver of COVID-19 severity. JCI Insight. 2021;6(15): e150107.","journal-title":"JCI Insight"},{"issue":"1","key":"1059_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jaip.2021.10.050","volume":"10","author":"B Ungar","year":"2022","unstructured":"Ungar B, Glickman JW, Golant AK, et al. COVID-19 symptoms are attenuated in moderate-to-severe atopic dermatitis patients treated with dupilumab. J Allergy Clin Immunol Pract. 2022;10(1):134\u201342.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01059-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01059-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01059-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T13:26:26Z","timestamp":1695216386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01059-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01059-9","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]},"assertion":[{"value":"27 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Xiyuan Zhou, Ge Yang, Xuejun Chen, and Lixia Zhang have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained from the Ethics Committee of Sichuan Provincial People\u2019s Hospital (Protocol 2022-327).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed an informed consent regarding publishing their data and photographs.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data are not publicly available because of privacy or ethical restrictions.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"XZ: methodology, formal analysis, investigation, visualization; GY: writing, original draft; XC: writing, review and editing, funding acquisition; LZ: conceptualization, project administration. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}